Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2010
03/24/2010EP2165711A1 Methods for treating bleeding disorders using sulfated polysaccharides
03/24/2010EP2165709A2 Lysine based compounds
03/24/2010EP2165704A1 Use of alverine for the treatment of cutaneous affections
03/24/2010EP2164843A1 Pyridazinone derivates
03/24/2010EP2164518A1 Formulations for the oral administration of therapeutic agents and related methods
03/24/2010EP2164517A1 Il- 18 and protein kinase r inhibition for the treatment of copd
03/24/2010EP2164492A1 (thio) -carbamoyl-cyclohexane derivatives and method for treating schizophrenia
03/24/2010EP1839662B1 Antitumor agent
03/24/2010EP1620060B1 Methods and devices for the sustained release of multiple drugs
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010EP1009399B1 Gaba analogs to prevent and treat gastrointestinal damage
03/24/2010CN101680887A Method of determining risk of scoliosis
03/24/2010CN101679251A (Aza)indole derivative and use thereof for medical purposes
03/24/2010CN101679244A 5-membered heterocyclic derivative and use thereof for medical purposes
03/24/2010CN101678113A Low-molecule drug-containing nanoparticle having sustained release negatively charged group
03/24/2010CN101678108A Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy
03/24/2010CN101678107A Drug combinations for the treatment of duchenne muscular dystrophy
03/24/2010CN101678106A Combination of Blys inhibition and/or APRIL inhibition and immunnosuppressants for treatment of autoimmune disease
03/24/2010CN101678105A Aliphatic acid-containing N-halogenated amino acid formulations
03/24/2010CN101678080A Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
03/24/2010CN101678078A SPARC and methods of use thereof
03/24/2010CN101678039A Mixture and method for reducing cholesterol using hydrophobic microparticles
03/24/2010CN101678037A Combined use of cholestanol derivative
03/24/2010CN101678034A methods for treating neovascular ocular diseases
03/24/2010CN101678031A Formulations containing triazinones and iron
03/24/2010CN101678029A Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders
03/24/2010CN101678025A Tetrahydrobiopterin compositions, and methods of measuring
03/24/2010CN101678006A Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
03/24/2010CN101678004A Triazol compounds for treating biofilm formation
03/24/2010CN101677984A Use of dimiracetam in the treatment of chronic pain
03/24/2010CN101677978A Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
03/24/2010CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine
03/24/2010CN101675936A Immunosuppressant
03/24/2010CN101675929A Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN101675922A Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
03/24/2010CN100595211C Angiopoietin-2 specific binding agents
03/24/2010CN100594935C Antibodies that immunospecifically bind to trail receptors
03/24/2010CN100594934C Amended recombinant cells (ARCs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants
03/24/2010CN100594933C Antiobestic agents and health foods
03/24/2010CN100594932C Tumor necrosis factor antagonists and their use in endometriosis
03/24/2010CN100594899C Sustained release system and method for ocular delivery of carbonic anhydrase inhibitors
03/24/2010CN100594887C Anticancer slow release injection comprising tetrazole violet and potentiating agent thereof
03/24/2010CN100594886C Anticancer slow release agent loading both newborn blood vessel and tetrazole violet
03/23/2010US7683059 Triazole compounds and uses related thereto
03/23/2010US7683049 beta -methyl carbapenem compounds; for multiple-drug resistant bacterial strain
03/23/2010US7683047 Treatment of conditions relating to hormone deficiencies by administration of progestins
03/23/2010US7683038 Such as gellan, carboxymethylcellulose, pectic acid, pectin and hyaluronic acid derivativesl; for use in the pharmaceutical, biomedical, surgical and healthcare fields
03/23/2010US7683037 Myocardial perfusion imaging method
03/23/2010US7683034 Use of enzyme inhibitors of aminopeptidase N and/or dipeptidylpeptidase IV
03/23/2010US7682807 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
03/23/2010US7682636 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
03/23/2010US7682632 Tamper-resistant oral opioid agonist formulations
03/23/2010US7682623 Pharmaceutical composition for topical application
03/23/2010CA2607237C The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
03/23/2010CA2446059C Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
03/23/2010CA2404278C Naphthalimide compositions and uses thereof
03/23/2010CA2399405C 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents
03/23/2010CA2390317C Product inhibiting transduction of g heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment
03/23/2010CA2389928C Method for treating diabetes
03/23/2010CA2389745C Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
03/23/2010CA2377278C Prodrugs of carbamate inhibitors of impdh
03/23/2010CA2364742C Anthelmintic composition
03/23/2010CA2356737C Tumor necrosis factor antagonists and their use in endometriosis
03/23/2010CA2332608C Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
03/23/2010CA2332488C Cells and animals deficient in protein kinase c epsilon
03/23/2010CA2309639C Small peptides and methods for treatment of asthma and inflammation
03/23/2010CA2305312C Mammalian genes involved in viral infection and tumor suppression
03/23/2010CA2209124C Antitumor agent effect enhancer containing il-6 antagonist
03/23/2010CA2203655C Tumor necrosis factor-gamma
03/23/2010CA2201774C Multi-faceted method to repress reproduction of latent viruses in humans and animals
03/23/2010CA2196656C Method for the preparation of (±)-calanolide a and intermediates thereof
03/23/2010CA2149818C Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders
03/18/2010WO2010030835A2 Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor
03/18/2010WO2010029996A1 Pharmaceutical composition
03/18/2010WO2010029312A1 Carbohydrate binding molecules
03/18/2010WO2010029131A1 Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
03/18/2010WO2010029104A2 Use of a pharmaceutical composition for the local treatment of infections, and medical product
03/18/2010WO2010029089A2 Combination therapy for the treatment of diabetes and related conditions
03/18/2010WO2010028845A2 Use of an ang-(1-7) receptor agonist in acute lung injury
03/18/2010WO2010028769A1 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus
03/18/2010WO2009142755A3 Methods of nourishing animals
03/18/2010WO2009126931A3 Therapy for bipolar disorder and mania with buprenorphine
03/18/2010WO2009120247A3 Lipid nanoparticle compositions and methods of making and using the same
03/18/2010WO2008154898A3 Preparation for the treatment of equine laminitis
03/18/2010US20100071079 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
03/18/2010US20100069402 Treatment of Behavioral Disorders
03/18/2010US20100069344 Small molecule antagonists of bcl2 family proteins
03/18/2010US20100069342 Formoterol/steroid bronchodilating compositions and methods of use thereof
03/18/2010US20100068313 Cranberry seed oil extract and compositions containing components thereof
03/18/2010US20100068269 Treatment and prevention of cardiovascular events
03/18/2010US20100068267 Compositions for treating vascular diseases characterized by nitric oxide insufficiency
03/18/2010US20100068261 Methods and compositions for the production of monoclonal antibodies
03/18/2010US20100068245 Preparation and storage of stable, biologically active materials
03/18/2010US20100068194 Composition for in vivo transplantation for treatment of human cervical cancer comprising mononuclear cells derived from umbilical cord blood
03/18/2010US20100068191 Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions
03/18/2010US20100068188 Composition for regeneration of periodontal hard tissue and method for regeneration of periodontal hard tissue
03/18/2010US20100068187 Transcription factors for differentiation of adult human olfactory progenitor cells
03/18/2010US20100068183 Methods of treating lysosomal storage related diseases by gene therapy
03/18/2010US20100068179 Phosphohalohydrins, Process For The Production Thereof And Use Thereof
1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 1151